More tools:Markets·Screener·Research·Chat

SenesTech, Inc. Common Stock (SNES) Financial Statements

SenesTech, Inc. Common Stock
SIC 2870 · AGRICULTURAL CHEMICALS
FIGI BBG002VBFQM8
XNAS · usd
0.89▼ 0.11 (-11.00%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close1.00
Day's Range0.84 – 1.04
52-Week Range0.84 – 5.35
Volume239.6K
Avg Volume113.2K
Share Statistics
Shares Outstanding
Employees24
ExchangeXNAS
Listed2016-12-08
Share count as of August 4, 2026
Loading Income Statement…
Key questions about SenesTech, Inc. Common Stock (SNES)
What is SenesTech, Inc. Common Stock's Market Cap?
SenesTech, Inc. Common Stock's Market Cap is $4.8M, based on as-reported figures from SEC (XBRL) filings.
What is SenesTech, Inc. Common Stock's Price / Sales?
SenesTech, Inc. Common Stock's Price / Sales is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is SenesTech, Inc. Common Stock's Revenue (TTM)?
SenesTech, Inc. Common Stock's Revenue (TTM) is $2.4M, based on as-reported figures from SEC (XBRL) filings.
What is SenesTech, Inc. Common Stock's Net Income (TTM)?
SenesTech, Inc. Common Stock's Net Income (TTM) is -$7.0M, based on as-reported figures from SEC (XBRL) filings.
What is SenesTech, Inc. Common Stock's EBITDA?
SenesTech, Inc. Common Stock's EBITDA is -$7.1M, based on as-reported figures from SEC (XBRL) filings.
What is SenesTech, Inc. Common Stock's Diluted EPS (TTM)?
SenesTech, Inc. Common Stock's Diluted EPS (TTM) is -1.29, based on as-reported figures from SEC (XBRL) filings.
What is SenesTech, Inc. Common Stock's EBITDA Margin?
SenesTech, Inc. Common Stock's EBITDA Margin is -298.5%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues, net
YoY growth+23.2%+1.6%-16.0%+43.2%
Cost of sales
Gross profit
% of revenue73.6%68.6%55.3%62.8%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue315.5%498.4%502.1%258.0%
Loss from operations
% of revenue-241.8%-429.8%-446.8%-195.2%
Interest income (expense):
Interest income
Interest expense
Interest income (expense), net
Net loss
% of revenue-237.9%-418.5%-428.5%-188.1%
Net loss per share - basic (in dollars per share)
Net loss per share - diluted (in dollars per share)